Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "Ibrutinib"

AbbVie to buy Pharmacyclics for pipeline boost
RSC

AbbVie to acquire Pharmacyclics

AbbVie, Inc. has signed a definitive agreement to acquire Pharmacyclics, Inc. and its flagship asset Imbruvica(R) (ibrutinib), a treatment for hematologic malignancies, for approximately $21,000 million. AbbVie and Pharmacyclics are US-based ... Individual.com, 3 weeks ago
AbbVie Acquires Oncology Drug Firm Pharmacyclics for $21B Genetic Engineering News, 3 weeks ago
[x]  

27 images for Ibrutinib

NewsReality.com, 3 days ago
OncLive, 6 days ago
Proactive Investors USA, 1 week ago
OncLive, 1 week ago
Cancernetwork.com, 3 weeks ago
RSC, 2 weeks ago
OncLive, 3 weeks ago
EurekAlert!, 3 weeks ago
KXXV-TV, 3 weeks ago
OncLive, 1 month ago

It's A Drug! It's A Pipeline! It's A New Blockbuster Model!

When AbbVie's CEO Rick Gonzalez described his recently acquired product ibrutinib (Imbruvica) as offering a pipeline in a drug, I imagine every business development executive in biopharma chuckled. No question each of them has used this exact line ...
 Forbes.com3 weeks ago

Addition of ibrutinib to chemoimmunotherapy shows promise for CLL

The addition of ibrutinib to chemoimmunotherapy enhanced clinical activity in previously treated patients with chronic lymphocytic leukemia patients, according to study results. The regimen also was well tolerated, results showed. Both ...
 Orthopedics Today1 day ago New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting  News-Medical.Net1 week ago New ibrutinib (IMBRUVICA®) Data to be Presented at American Association for Cancer Research (AACR) Meeting  Financial Content1 week ago Independent Data Monitoring Committee Unanimously Recommends Unblinding of IMBRUVICA® (ibrutinib) Phase III Combination HELIOS Trial Based on Interim Analysis Showing Significant Improvement in Progre  BioSpace1 week ago
[x]  
Catholic Online

New drug may actually stave off chemotherapy

Miracle drug Ibrutinib could spare blood cancer patients painful chemotherapy Ibrutinib, hailed as a revolutionary drug capable of "switching off" cancer may soon be offered to patients with some forms of the disease. The once-a-day tablet ...
 Catholic Online3 days ago Doctors hail drug that can 'turn off cancer': Once-a-day tablet could spare blood cancer patients effects of traditional chemotherapy  Capital Bay5 days ago New drug hope for blood cancers  Yahoo! UK and Ireland1 month ago Blood cancer pill offers fresh hope for thousands of leukaemia sufferers  Irish Mirror1 month ago

[Articles] Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with aberrations: a phase 2, single-arm trial

The activity and safety profile of single-agent ibrutinib in CLL with TP53 aberrations is encouraging and supports its consideration as a novel treatment option for patients with this high-risk disease in both first-line and
 Lancet Neurology1 month ago

Phase 3 Study with IMBRUVICA® (ibrutinib) Combination Demonstrates Significant Delay in Disease Progression

/PRNewswire/ --Janssen Research & Development, LLC (Janssen) announced today that a pre-planned interim analysis of the Phase 3 HELIOS (CLL3001) study investigating the combination of IMBRUVICA ® (ibrutinib) plus bendamustine and rituximab (BR) ...
 RCL Advisors1 week ago Phase 3 Study with IMBRUVICA (ibrutinib) Combination Demonstrates Significant Delay in Disease Progression  FirstWord Pharma1 week ago Phase 3 Study with IMBRUVICA?? (ibrutinib) Combination Demonstrates Significant Delay in Disease Progression  Tutorial Finder1 week ago Phase 3 Study with IMBRUVICA(r) (ibrutinib) Combination Demonstrates  Finwin1 week ago
[x]  
EurekAlert!

Ibrutinib discontinuation linked to poor prognosis in CLL

Discontinuation of ibrutinib therapy for chronic lymphocytic leukemia due to progressive disease was associated with a poor prognosis, especially among patients with Richter's transformation, according to study results. Results also indicated BTK ...
 Orthopedics Today2 weeks ago CLL patients discontinue ibrutinib drug due to disease progression during clinical trials  News-Medical.Net3 weeks ago Prognosis With Ibrutinib Discontinuation in CLL Identified  Monthly Prescribing Reference3 weeks ago Researchers Examine Etiology of Ibrutinib Discontinuation in CLL  Physician's Briefing4 weeks ago
[x]  

Pharmacyclics Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Updates

Key Highlights In the first full year of IMBRUVICA ® (ibrutinib) sales, the Company recorded total revenue of $730 million , driven by U.S. net product revenue of $492 million for the year ended December 31, 2014 , compared to U.S. net product ...
 Morningstar.com1 month ago Pharmacyclics, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business Updates  BioSpace1 month ago PHARMACYCLICS : Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Updates  4 Traders1 month ago
[x]  

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

 A.M. Best1 month ago LLS Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia  Noodls1 month ago IWMF President Applauds First Approval for Waldenstrom's Macroglobulinemia  CURE Magazine1 month ago
[x]  

IMBRUVICA® (ibrutinib) receives expanded approval for treatment of Waldenstrom's macroglobulinemia

 A.M. Best1 month ago IMBRUVICA (ibrutinib) receives expanded approval for treatment of Waldenstrom's macroglobulinemia  Pharmacy Choice1 month ago IMBRUVICA(r) (ibrutinib) receives expanded approval for treatment of  Finwin1 month ago Press Release: IMBRUVICA(R) (ibrutinib) receives expanded approval for treatment of Waldenstrom's macroglobulinemia  iMarketReports1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less